Free-cash-flow proxy decreased 45.5%
Free-cash-flow proxy changed -45.5% from the comparable as-filed period.
-$10.0M→-$14.6M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BBNX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 56.1%
Operating income changed -56.1% from the comparable as-filed period.
-$17.0M→-$26.6M2 prior comparisons
Operating cash flow decreased 40.8%
Operating cash flow changed -40.8% from the comparable as-filed period.
-$8.7M→-$12.3M2 prior comparisons
Net income decreased 71.4%
Net income changed -71.4% from the comparable as-filed period.
-$14.2M→-$24.4M2 prior comparisons
Revenue increased 30.3%
Revenue changed +30.3% from the comparable as-filed period.
$27.3M→$35.5M2 prior comparisons
Operating margin moved 1241 bp lower
Operating margin changed -1241 basis points from the comparable as-filed period.
-62.54%→-74.94%2 prior comparisons
Research & development increased 46.1%
Research & development changed +46.1% from the comparable as-filed period.
$8.2M→$12.0M2 prior comparisons
Cash & equivalents increased 111.9%
Cash & equivalents changed +111.9% from the comparable as-filed period.
$38.5M→$81.6M2 prior comparisons
Inventory / revenue moved 1006 bp lower
Inventory / revenue changed -1006 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
74.76%→64.70%2 prior comparisons
Trade receivables increased 79.1%
Trade receivables changed +79.1% from the comparable as-filed period.
$11.5M→$20.7M3 prior comparisons
Gross profit increased 34.5%
Gross profit changed +34.5% from the comparable as-filed period.
$15.1M→$20.3M2 prior comparisons
Current liabilities increased 29.3%
Current liabilities changed +29.3% from the comparable as-filed period.
$25.4M→$32.8M3 prior comparisons
Gross margin moved 179 bp higher
Gross margin changed +179 basis points from the comparable as-filed period.
55.48%→57.26%2 prior comparisons
Stock-based compensation increased 50.0%
Stock-based compensation changed +50.0% from the comparable as-filed period.
$4.5M→$6.7M2 prior comparisons
Total assets increased 34.5%
Total assets changed +34.5% from the comparable as-filed period.
$330.0M→$443.8M3 prior comparisons
Operating income decreased 28.7%
Operating income changed -28.7% from the comparable as-filed period.
-$19.9M→-$25.6M2 prior comparisons
Net income decreased 38.7%
Net income changed -38.7% from the comparable as-filed period.
-$16.9M→-$23.4M2 prior comparisons
Gross margin moved 524 bp higher
Gross margin changed +524 basis points from the comparable as-filed period.
53.80%→59.04%2 prior comparisons
Revenue increased 37.8%
Revenue changed +37.8% from the comparable as-filed period.
$23.2M→$32.0M2 prior comparisons
Operating margin moved 562 bp higher
Operating margin changed +562 basis points from the comparable as-filed period.
-85.52%→-79.90%2 prior comparisons
Capex / revenue moved 441 bp lower
Capex / revenue changed -441 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.66%→3.25%2 prior comparisons
Cash & equivalents increased 26.4%
Cash & equivalents changed +26.4% from the comparable as-filed period.
$35.1M→$44.3M2 prior comparisons
Current liabilities increased 33.5%
Current liabilities changed +33.5% from the comparable as-filed period.
$19.5M→$26.0M3 prior comparisons
Gross profit increased 51.2%
Gross profit changed +51.2% from the comparable as-filed period.
$12.5M→$18.9M2 prior comparisons
Inventory increased 38.1%
Inventory changed +38.1% from the comparable as-filed period.
$17.3M→$23.9M3 prior comparisons
Trade receivables increased 58.4%
Trade receivables changed +58.4% from the comparable as-filed period.
$11.4M→$18.1M3 prior comparisons
Capital expenditure decreased 41.6%
Capital expenditure changed -41.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$1.8M→$1.0M3 prior comparisons
Stock-based compensation increased 46.2%
Stock-based compensation changed +46.2% from the comparable as-filed period.
$4.8M→$7.0M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.